本页面由Tiger Trade Technology Pte. Ltd.提供服务

Jasper Therapeutics

0.4956
-0.0594-10.70%
盘后:0.4955-0.0001-0.02%16:45 EDT
成交量:42.73万
成交额:21.98万
市值:1,649.09万
市盈率:-0.53
高:0.5400
开:0.5400
低:0.4956
收:0.5550
52周最高:2.69
52周最低:0.3151
股本:3,327.46万
流通股本:2,999.67万
量比:1.29
换手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):-0.9300
每股收益(LYR):-3.9545
净资产收益率:-255.05%
总资产收益率:-113.41%
市净率:11.67
市盈率(LYR):-0.13

数据加载中...

2025/03/25

SEC问询函

Form CORRESP - Correspondence
2025/03/19

重要事件披露

Form 8-K - Current report
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments